- Home
- HAO vs QLGN Comparison
HAO vs QLGN Comparison
Compare HAO & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAO
- QLGN
- Stock Information
- Founded
- HAO 2018
- QLGN 1996
- Country
- HAO China
- QLGN United States
- Employees
- HAO N/A
- QLGN N/A
- Industry
- HAO
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- HAO
- QLGN Health Care
- Exchange
- HAO NYSE
- QLGN Nasdaq
- Market Cap
- HAO 3.3M
- QLGN 2.8M
- IPO Year
- HAO 2024
- QLGN N/A
- Fundamental
- Price
- HAO $1.27
- QLGN $3.54
- Analyst Decision
- HAO
- QLGN
- Analyst Count
- HAO 0
- QLGN 0
- Target Price
- HAO N/A
- QLGN N/A
- AVG Volume (30 Days)
- HAO 67.5K
- QLGN 9.1K
- Earning Date
- HAO 07-07-2025
- QLGN 08-13-2025
- Dividend Yield
- HAO N/A
- QLGN N/A
- EPS Growth
- HAO N/A
- QLGN N/A
- EPS
- HAO 0.19
- QLGN N/A
- Revenue
- HAO $48,970,924.00
- QLGN N/A
- Revenue This Year
- HAO N/A
- QLGN N/A
- Revenue Next Year
- HAO N/A
- QLGN N/A
- P/E Ratio
- HAO $6.50
- QLGN N/A
- Revenue Growth
- HAO 15.04
- QLGN N/A
- 52 Week Low
- HAO $0.84
- QLGN $2.85
- 52 Week High
- HAO $173.25
- QLGN $29.44
- Technical
- Relative Strength Index (RSI)
- HAO 46.49
- QLGN 44.87
- Support Level
- HAO $1.18
- QLGN $3.37
- Resistance Level
- HAO $1.31
- QLGN $3.85
- Average True Range (ATR)
- HAO 0.08
- QLGN 0.23
- MACD
- HAO -0.00
- QLGN -0.03
- Stochastic Oscillator
- HAO 46.63
- QLGN 34.29
About HAO HAOXI HEALTH TECHNOLOGY LTD
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.